Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,870,725
-
Share change
-
-60,890
-
Total reported value
-
$116,517,745
-
Put/Call ratio
-
144%
-
Price per share
-
$40.58
-
Number of holders
-
65
-
Value change
-
-$2,569,356
-
Number of buys
-
21
-
Number of sells
-
33
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2025
As of 30 Jun 2025 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,870,725 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, Kingsview Wealth Management, LLC, FIRST CITIZENS BANK & TRUST CO, Envestnet Portfolio Solutions, Inc., GOLDMAN SACHS GROUP INC, LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and WELLS FARGO & COMPANY/MN.
This table shows 65 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.